According to Alaunos Therapeutics's latest financial reports the company has a price-to-book ratio of 3.35.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.70 | -33.36% |
2022-12-31 | 4.05 | -0.25% |
2021-12-31 | 4.06 | -6.97% |
2020-12-31 | 4.36 | -51.71% |
2019-12-31 | 9.03 | 156.58% |
2018-12-31 | 3.52 | -71.74% |
2017-12-31 | 12.5 | -15.13% |
2016-12-31 | 14.7 | 17.14% |
2015-12-31 | 12.5 | -19.94% |
2014-12-31 | 15.6 | 77.78% |
2013-12-31 | 8.80 | 23.15% |
2012-12-31 | 7.15 | 69.55% |
2011-12-31 | 4.22 | -42.97% |
2010-12-31 | 7.39 | 68.78% |
2009-12-31 | 4.38 | 138.08% |
2008-12-31 | 1.84 | -25.9% |
2007-12-31 | 2.48 | -27.75% |
2006-12-31 | 3.44 | 5.06% |
2005-12-31 | 3.27 | |
2004-12-31 | N/A | |
2003-12-31 | N/A | |
2002-12-31 | N/A |